Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risk factors of airway obstruction after drug-induced sleep
ChiCTR2100042083Phase 4Recruiting
- Sponsor
- Guangdong Provincial People's Hospital Zhuhai Hospital
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in Airway Obstruction (AO) and sleep disordered breathing (SDB) comparing Midazolam group with Esketamine group (2 arms). Primary endpoint: Grade of airway obstruction. Started Feb 2021; status: recruiting.
02
Drugs
midazolamesketamine
03
Conditions
Airway Obstruction (AO)sleep disordered breathing (SDB)
Beyond the preview
Go deeper on ChiCTR2100042083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100042083.